| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |